30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

CG Oncology Inc (CGON)

Track

Over the last 90 days, CG Oncology Inc. has seen 7 insider transactions totaling $2.7 million in sales, with no reported buys. This activity is primarily driven by planned and proposed sales from directors and other insiders. The company's stock has experienced an 8.5% decrease in price over the past 90 days.
Stock chart
Ticker: CGON Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Mulay James
2 sales — total 200,000 USD
Planned sale 15 Jun 2026
Value US$4,067,933.68 | Price 231.31 | Shares 92,289
Planned sale 15 Jun 2026
Value US$2,270,914.58 | Price 390.04 | Shares 73,687
Planned sale 4 Jun 2026
Value US$4,592,055.14 | Price 152.94 | Shares 10,869
Planned sale 4 Jun 2026
Value US$2,926,324.67 | Price 369.85 | Shares 92,766
Proposed sale 4 Jun 2026
Value US$100,000.00 | Price 54.42 | Shares 1,000
Planned sale 17 Apr 2026
Value US$1,138,956.00 | Price 73.01 | Shares 15,600
Proposed sale 17 Apr 2026
Value US$1,165,195.76 | Price 66.34 | Shares 17,564
Planned sale 16 Mar 2026
Value US$83,185.00 | Price 63.50 | Shares 1,310
Planned sale 16 Mar 2026
Value US$41,529.00 | Price 63.50 | Shares 654
Planned sale 9 Jan 2026
Value US$555,918.09 | Price 52.99 | Shares 10,491
Planned sale 9 Jan 2026
Value US$28,880.64 | Price 44.16 | Shares 654
Proposed sale 9 Jan 2026
Value US$549,660.37 | Price 41.93 | Shares 13,109
Planned sale 17 Nov 2025
Value US$41,430.00 | Price 41.43 | Shares 1,000
Planned sale 13 Oct 2025
Value US$43,250.00 | Price 43.25 | Shares 1,000
Planned sale 9 Oct 2025
Value US$259,672.97 | Price 43.99 | Shares 5,903
Proposed sale 9 Oct 2025
Value US$266,935.47 | Price 40.71 | Shares 6,557
Planned sale 30 Sep 2025
Value US$200,450.00 | Price 40.09 | Shares 5,000
Planned sale 29 Sep 2025
Value US$499,868.45 | Price 39.19 | Shares 12,755
Planned sale 19 Sep 2025
Value US$139,350.26 | Price 38.99 | Shares 3,574
Planned sale 18 Sep 2025
Value US$745,559.12 | Price 39.01 | Shares 19,112
Proposed sale 18 Sep 2025
Value US$1,336,834.52 | Price 37.72 | Shares 35,441
Planned sale 15 Sep 2025
Value US$35,100.00 | Price 35.10 | Shares 1,000
Proposed sale 15 Sep 2025
Value US$100,020.00 | Price 33.34 | Shares 3,000
Buy 11 Sep 2025
Value US$49,999,983.00 | Price 33.00 | Shares 1,515,151
Planned sale 5 Sep 2025
Value US$103,413.86 | Price 33.22 | Shares 3,113
Planned sale 5 Sep 2025
Value US$243,657.60 | Price 32.64 | Shares 7,465
Planned sale 5 Sep 2025
Value US$128,664.90 | Price 31.42 | Shares 4,095
Planned sale 5 Sep 2025
Value US$376,060.74 | Price 30.47 | Shares 12,342
Proposed sale 5 Sep 2025
Value US$835,844.10 | Price 30.94 | Shares 27,015
Sale 3 Sep 2025
Value US$2,899.00 | Price 28.99 | Shares 100
Sale 3 Sep 2025
Value US$2,896.00 | Price 28.96 | Shares 100
Sale 3 Sep 2025
Value US$850,165.20 | Price 28.24 | Shares 30,105
Sale 3 Sep 2025
Value US$1,923,582.00 | Price 27.60 | Shares 69,695
Planned sale 3 Sep 2025
Value US$28,000.00 | Price 28.00 | Shares 1,000
Proposed sale 3 Sep 2025
Value US$2,746,000.00 | Price 27.46 | Shares 100,000
Proposed sale 3 Sep 2025
Value US$27,460.00 | Price 27.46 | Shares 1,000
Planned sale 17 Jul 2025
Value US$56,000.00 | Price 28.00 | Shares 2,000
Proposed sale 17 Jul 2025
Value US$52,160.00 | Price 26.08 | Shares 2,000
Planned sale 21 May 2025
Value US$28,000.00 | Price 28.00 | Shares 1,000
Planned sale 28 Apr 2025
Value US$30,760.00 | Price 30.76 | Shares 1,000
Planned sale 17 Mar 2025
Value US$28,000.00 | Price 28.00 | Shares 1,000
Proposed sale 17 Mar 2025
Value US$111,200.00 | Price 27.80 | Shares 4,000
Planned sale 18 Feb 2025
Value US$28,610.00 | Price 28.61 | Shares 1,000
Planned sale 13 Jan 2025
Value US$29,660.00 | Price 29.66 | Shares 1,000
Sale 16 Dec 2024
Value US$19,600,000.00 | Price 28.00 | Shares 700,000
Planned sale 16 Dec 2024
Value US$28,840.00 | Price 28.84 | Shares 1,000
Proposed sale 6 Dec 2024
Value US$134,240.00 | Price 33.56 | Shares 4,000
Planned sale 6 Dec 2024
Value US$8,744.00 | Price 34.98 | Shares 250
Planned sale 6 Dec 2024
Value US$25,797.98 | Price 34.40 | Shares 750
Sale 29 Aug 2024
Value US$8,000,023.20 | Price 35.36 | Shares 226,245
Sale 29 Aug 2024
Value US$15,000,065.60 | Price 35.36 | Shares 424,210
Proposed sale 29 Aug 2024
Value US$15,000,000.00 | Price 35.36 | Shares 424,210
Proposed sale 29 Aug 2024
Value US$15,000,000.00 | Price 35.36 | Shares 424,210
Proposed sale 29 Aug 2024
Value US$8,000,000.00 | Price 35.36 | Shares 226,245
Proposed sale 29 Aug 2024
Value US$8,000,000.00 | Price 35.36 | Shares 226,245
Buy 29 Jan 2024
Value US$24,985.00 | Price 19.00 | Shares 1,315
Buy 29 Jan 2024
Value US$4,999,983.00 | Price 19.00 | Shares 263,157
Buy 29 Jan 2024
Value US$38,000.00 | Price 19.00 | Shares 2,000
Buy 29 Jan 2024
Value US$7,600,000.00 | Price 19.00 | Shares 400,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-16 2026-06-15 PlS Planned sale
Mulay James
Non-Executive Director
92,289 +37.4%
231.31
US$4,067,934 		92,289 +37.4% 231.31 US$4,067,934
2026-06-16 2026-06-15 PlS Planned sale
Mulay James
Non-Executive Director
73,687 -13.3%
390.04
US$2,270,915 		73,687 -13.3% 390.04 US$2,270,915
2026-06-05 2026-06-04 PlS Planned sale
3.0
POST LEONARD E
Non-Executive Director
10,869 -35.8%
152.94
US$4,592,055 		10,869 -35.8% 152.94 US$4,592,055
2026-06-05 2026-06-04 PlS Planned sale
3.0
POST LEONARD E
Non-Executive Director
1,000 -100.0%
54.50
US$100,000 		1,000 -100.0% 54.50 US$100,000
2026-06-04 2026-06-04 PrS Proposed sale
3.0
LEONARD E POST

Director

Non-Executive Director
1,000
54.42
US$100,000 		1,000 54.42 US$100,000
2026-04-20 2026-04-17 PlS Planned sale
Mulay James
Non-Executive Director
15,600 -100.0%
73.01
US$1,138,956 		15,600 -100.0% 73.01 US$1,138,956
2026-04-17 2026-04-17 PrS Proposed sale
JAMES MULE

Director

Non-Executive Director
17,564
66.34
US$1,165,196 		17,564 66.34 US$1,165,196
2026-03-17 2026-03-16 PlS Planned sale
Mulay James
Non-Executive Director
1,310 -100.0%
63.50
US$83,185 		1,310 -100.0% 63.50 US$83,185
2026-03-17 2026-03-16 PlS Planned sale
Mulay James
Non-Executive Director
654 -100.0%
63.50
US$41,529 		654 -100.0% 63.50 US$41,529
2026-01-13 2026-01-09 PlS Planned sale
Mulay James
Non-Executive Director
10,491 -100.0%
52.99
US$555,918 		10,491 -100.0% 52.99 US$555,918
2026-01-13 2026-01-09 PlS Planned sale
Mulay James
Non-Executive Director
654 -100.0%
44.16
US$28,881 		654 -100.0% 44.16 US$28,881
2026-01-09 2026-01-09 PrS Proposed sale
JAMES MULAY

Director

Non-Executive Director
13,109
41.93
US$549,660 		13,109 41.93 US$549,660
2025-11-18 2025-11-17 PlS Planned sale
3.0
POST LEONARD E
Non-Executive Director
1,000 -100.0%
41.43
US$41,430 		1,000 -100.0% 41.43 US$41,430
2025-10-15 2025-10-13 PlS Planned sale
3.0
POST LEONARD E
Non-Executive Director
1,000 -100.0%
43.25
US$43,250 		1,000 -100.0% 43.25 US$43,250
2025-10-10 2025-10-09 PlS Planned sale
Mulay James
Non-Executive Director
5,903 -100.0%
43.99
US$259,673 		5,903 -100.0% 43.99 US$259,673
2025-10-09 2025-10-09 PrS Proposed sale
JAMES MULAY

Director

Non-Executive Director
6,557
40.71
US$266,935 		6,557 40.71 US$266,935
2025-10-01 2025-09-30 PlS Planned sale
3.0
POST LEONARD E
Non-Executive Director
5,000 -100.0%
40.09
US$200,450 		5,000 -100.0% 40.09 US$200,450
2025-09-30 2025-09-29 PlS Planned sale
Mulay James
Non-Executive Director
12,755 -100.0%
39.19
US$499,868 		12,755 -100.0% 39.19 US$499,868
2025-09-22 2025-09-19 PlS Planned sale
Mulay James
Non-Executive Director
3,574 -100.0%
38.99
US$139,350 		3,574 -100.0% 38.99 US$139,350
2025-09-22 2025-09-18 PlS Planned sale
Mulay James
Non-Executive Director
19,112 -100.0%
39.01
US$745,559 		19,112 -100.0% 39.01 US$745,559
2025-09-18 2025-09-18 PrS Proposed sale
JAMES MULAY

Director

Non-Executive Director
35,441
37.72
US$1,336,835 		35,441 37.72 US$1,336,835
2025-09-16 2025-09-15 PlS Planned sale
3.0
POST LEONARD E
Non-Executive Director
1,000 -100.0%
35.10
US$35,100 		1,000 -100.0% 35.10 US$35,100
2025-09-15 2025-09-15 PrS Proposed sale
3.0
LEONARD E POST

Director

Non-Executive Director
3,000
33.34
US$100,020 		3,000 33.34 US$100,020
2025-09-15 2025-09-11 B Purchase
3.3
Liu Brian Guan-Chyun
Non-Executive Director
1,515,151 +inf%
33.00
US$49,999,983 		1,515,151 +inf% 33.00 US$49,999,983
2025-09-08 2025-09-05 PlS Planned sale
Mulay James
Non-Executive Director
3,113 -100.0%
33.22
US$103,414 		3,113 -100.0% 33.22 US$103,414
2025-09-08 2025-09-05 PlS Planned sale
Mulay James
Non-Executive Director
7,465 -70.6%
32.64
US$243,658 		7,465 -70.6% 32.64 US$243,658
2025-09-08 2025-09-05 PlS Planned sale
Mulay James
Non-Executive Director
4,095 -27.9%
31.42
US$128,665 		4,095 -27.9% 31.42 US$128,665
2025-09-08 2025-09-05 PlS Planned sale
Mulay James
Non-Executive Director
12,342 -45.7%
30.47
US$376,061 		12,342 -45.7% 30.47 US$376,061
2025-09-05 2025-09-05 PrS Proposed sale
JAMES MULAY

Director

Non-Executive Director
27,015
30.94
US$835,844 		27,015 30.94 US$835,844
2025-09-04 2025-09-03 S Sale
2.6
Song Hong Fang
Non-Executive Director
100 -0.0%
28.99
US$2,899 		100 -0.0% 28.99 US$2,899
2025-09-04 2025-09-03 S Sale
2.6
Song Hong Fang
Non-Executive Director
100 -0.0%
28.96
US$2,896 		100 -0.0% 28.96 US$2,896
2025-09-04 2025-09-03 S Sale
2.6
Song Hong Fang
Non-Executive Director
30,105 -1.0%
28.24
US$850,165 		30,105 -1.0% 28.24 US$850,165
2025-09-04 2025-09-03 S Sale
2.6
Song Hong Fang
Non-Executive Director
69,695 -2.3%
27.60
US$1,923,582 		69,695 -2.3% 27.60 US$1,923,582
2025-09-04 2025-09-03 PlS Planned sale
3.0
POST LEONARD E
Non-Executive Director
1,000 -100.0%
28.00
US$28,000 		1,000 -100.0% 28.00 US$28,000
2025-09-03 2025-09-03 PrS Proposed sale
Charming Jade Ltd

Director

Non-Executive Director
100,000
27.46
US$2,746,000 		100,000 27.46 US$2,746,000
2025-09-03 2025-09-03 PrS Proposed sale
3.0
LEONARD E POST

Director

Non-Executive Director
1,000
27.46
US$27,460 		1,000 27.46 US$27,460
2025-07-18 2025-07-17 PlS Planned sale
3.0
POST LEONARD E
Non-Executive Director
2,000 -100.0%
28.00
US$56,000 		2,000 -100.0% 28.00 US$56,000
2025-07-17 2025-07-17 PrS Proposed sale
3.0
LEONARD E POST

Director

Non-Executive Director
2,000
26.08
US$52,160 		2,000 26.08 US$52,160
2025-05-22 2025-05-21 PlS Planned sale
3.0
POST LEONARD E
Non-Executive Director
1,000 -100.0%
28.00
US$28,000 		1,000 -100.0% 28.00 US$28,000
2025-04-29 2025-04-28 PlS Planned sale
3.0
POST LEONARD E
Non-Executive Director
1,000 -100.0%
30.76
US$30,760 		1,000 -100.0% 30.76 US$30,760
2025-03-18 2025-03-17 PlS Planned sale
3.0
POST LEONARD E
Non-Executive Director
1,000 -100.0%
28.00
US$28,000 		1,000 -100.0% 28.00 US$28,000
2025-03-17 2025-03-17 PrS Proposed sale
3.0
LEONARD E POST

Director

Non-Executive Director
4,000
27.80
US$111,200 		4,000 27.80 US$111,200
2025-02-19 2025-02-18 PlS Planned sale
3.0
POST LEONARD E
Non-Executive Director
1,000 -100.0%
28.61
US$28,610 		1,000 -100.0% 28.61 US$28,610
2025-01-14 2025-01-13 PlS Planned sale
3.0
POST LEONARD E
Non-Executive Director
1,000 -100.0%
29.66
US$29,660 		1,000 -100.0% 29.66 US$29,660
2024-12-17 2024-12-16 S Sale
2.6
Song Hong Fang
Non-Executive Director
700,000 -18.9%
28.00
US$19,600,000 		700,000 -18.9% 28.00 US$19,600,000
2024-12-17 2024-12-16 PlS Planned sale
3.0
POST LEONARD E
Non-Executive Director
1,000 -100.0%
28.84
US$28,840 		1,000 -100.0% 28.84 US$28,840
2024-12-06 2024-12-06 PrS Proposed sale
3.0
LEONARD E POST

Director

Non-Executive Director
4,000
33.56
US$134,240 		4,000 33.56 US$134,240
2024-12-06 2024-12-06 PlS Planned sale
3.0
POST LEONARD E
Non-Executive Director
250 -100.0%
34.98
US$8,744 		250 -100.0% 34.98 US$8,744
2024-12-06 2024-12-06 PlS Planned sale
3.0
POST LEONARD E
Non-Executive Director
750 -75.0%
34.40
US$25,798 		750 -75.0% 34.40 US$25,798
2024-08-30 2024-08-29 S Sale
2.6
Song Hong Fang
Non-Executive Director
226,245 -5.8%
35.36
US$8,000,023 		226,245 -5.8% 35.36 US$8,000,023
2024-08-30 2024-08-29 S Sale
2.6
Song Hong Fang
Non-Executive Director
424,210 -42.0%
35.36
US$15,000,066 		424,210 -42.0% 35.36 US$15,000,066
2024-08-29 2024-08-29 PrS Proposed sale
Unique Diamond Investments Ltd

Director

Non-Executive Director
424,210
35.36
US$15,000,000 		424,210 35.36 US$15,000,000
2024-08-29 2024-08-29 PrS Proposed sale
Charming Jade Ltd

Director

Non-Executive Director
226,245
35.36
US$8,000,000 		226,245 35.36 US$8,000,000
2024-08-29 2024-08-29 PrS Proposed sale
Unique Diamond Investments Ltd

Director

Non-Executive Director
424,210
35.36
US$15,000,000 		424,210 35.36 US$15,000,000
2024-08-29 2024-08-29 PrS Proposed sale
Charming Jade Ltd

Director

Non-Executive Director
226,245
35.36
US$8,000,000 		226,245 35.36 US$8,000,000
2024-01-31 2024-01-29 B Purchase
Kasturi Vijay

Chief Medical Officer

Officer
1,315 +inf%
19.00
US$24,985 		1,315 +inf% 19.00 US$24,985
2024-01-31 2024-01-29 B Purchase
2.6
Song Hong Fang
Non-Executive Director
263,157 +75.0%
19.00
US$4,999,983 		263,157 +75.0% 19.00 US$4,999,983
2024-01-31 2024-01-29 B Purchase
Roche Corleen M.

CFO & Secretary

Officer
2,000 +inf%
19.00
US$38,000 		2,000 +inf% 19.00 US$38,000
2024-01-31 2024-01-29 B Purchase
Decheng Capital Global Life Sciences Fund IV, L.P.
Large shareholder
400,000 +inf%
19.00
US$7,600,000 		400,000 +inf% 19.00 US$7,600,000
Explore more

More insider trading research around CG Oncology Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America